Granulomatous mass in a nonrefluxing renal unit after bacillus calmette- guerin therapy for bladder cancer

Journal of Urology

Volumn 158, Issue 3, 1997, Pages 882-883

  Siskron IV, F Thomas ^a   Venable, Dennis D ^a   Gonzalez, Enrique ^a   Eastham, James A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

BCG vaccine; Bladder; Granuloma

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRIDOXINE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; GRANULOMA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL; SEPSIS; TRANSITIONAL CELL CARCINOMA; TUBERCULOSIS;

EID: 0030854078     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64348-9     Document Type: Article

References (3)

1. Lamm, D. L., van der Meijden, P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A. and Debruyne, F. M. J.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147: 596, 1992.
2. de Boisgisson, P. H., Roussel, F., Leclerc, D. and Picquenot, J. M.: Granulomatous renal mass during endovesical BCG therapy for bladder carcinoma. Diagnosis by fine needle aspiration. Urology, 37: 557, 1991.
3. Stanisic, T. H., Brewer, M. L. and Graham, A. R.: Intravesical bacillus Calmette-Guerin therapy and associated granulomatous renal masses. J. Urol., 135: 356, 1986.